Job Description

The Position

Lead the Future of Medicine – as Head of ExpMED ONC Immunotherapy.


To ensure the fastest and most focused path from strategy to patients, we are evolving our OneHP organization. Together, we are simplifying our structures, strengthening the accountability of Therapeutic Areas, and creating clear interfaces between Innovation and Business. This ensures that our assets are efficiently transformed into successful brands – with the ultimate goal of delivering lasting value to patients around the world.


Therefore, we are looking for a visionary leader to help shape our newly established Global Experimental Medicine organization. Your mission: elevate early clinical development, accelerate the path to Proof of Concept, and pave the way for breakthrough therapies.


Now is the time to act – to strengthen our organization, empower our teams, and fulfill our responsibility to patients worldwide.


Join us in shaping the future of medicine – apply now!


This position has a hybrid setup with approximately 2-3 days per week on site.

Tasks & responsibilities

In your new role, you will lead cross-functional teams in Experimental Medicine Oncology, driving the Clinical Development Plan (CDP) and its implementation and execution and representing the team at key decision-making committees. You will develop and implement innovative Clinical Development Plans (CDP) with an end-to-end path in mind, leading asset transitions from preclinical to clinical stages and evidence generation from CTA/IND enabling activities up to the Proof of Concept studies. Furthermore, you will align, coordinate, and manage information flow within the team to ensure timely execution of development strategies. You will evaluate and integrate new scientific data and technologies to enhance clinical development processes and outcomes. Moreover, you will act as a subject matter expert, providing guidance and mentorship in clinical drug research and development. You will establish and manage strategic partnerships and collaborations with external stakeholders to leverage external expertise and resources. In addition, you will be accountable for the budget, timelines, and deliverables of early clinical development programs, ensuring projects meet their objectives. You will ensure compliance with all relevant regulations, including ICH GCP, to maintain the safety, rights, and well-being of trial subjects.

Requirements

MD-PhD or MD with long-standing experience within the pharmaceutical industry, CROs, or regulatory authorities with experience in key therapeutic modalities immunotherapies and targeted therapies, ideally specialization / board certification in medical oncology, hematology or organ specialist Senior professional with several years of integrative leading experience in a matrix environment and with multi-year year experience in early clinical development including e.g. translational or biomarker research Proven leadership skills in global settings with inspirational team management and exceptional communication and presentation abilities Expertise in leading complex international projects with a history of driving innovation Deep understanding of business-relevant tools, technology oversight, and competitive dynamics Solid knowledge of drug development processes with strong project management and matrix leadership experience as well as skills in problem identification, meeting facilitation, and training delivery Strong teamwork and interpersonal skills, able to engage with various internal and external partners Fluency in English written and spoken required

Ready to contact us?

If you have any questions about the job posting or process - please contact our HR Direct Team, Tel: +49 (0) 6132 77-3330 or via mail: hr.de@boehringer-ingelheim.com




Recruitment process:


Step 1: Online application - The job posting is online until October 23rd, 2025.


Step 2: Virtual meetings early till mid of November


Step 3: On-site interviews starting end of November